DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Indobufen
Indobufen
(12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al
Characterising the Risk of Major Bleeding in Patients With
)&F1y3x PHARMACEUTICAL APPENDIX to THE
Anticoagulant Activities of Indobufen, an Antiplatelet Drug
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Section B Changed Classes/Guidelines Final
(12) United States Patent (10) Patent No.: US 8,080,578 B2 Liggett Et Al
Supplemental Material Liu Page 1
Meta-Regression of Randomized Control Trials with Antithrombotics
( 12 ) United States Patent
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Indobufen a Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in Cerebral, Peripheral and Coronary Vascular Disease
United States Patent (19) 11 Patent Number: 5,916,910 Lai (45) Date of Patent: Jun
Aspirin in Coronary Artery Disease an Appraisal of Functions and Limitations
5051881.Pdf (2.227Mb)
Stembook 2018.Pdf
An Open-Label, Multicenter, Expanded Access Study Of
Head Injury Partial Update
Top View
Management of Antithrombotic Drugs in Association with Endoscopic
Appendix: Drug Dosing in Renal Failure
Reproductive Health Guideline Appendix 3 – Search Strategies
Non-Steroidal Anti-Inflammatory Drug Effects on Core Temperature
8-11 January 2018 PRAC Meeting Minutes
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Systemic Glucocorticoids in the Treatment of COVID-19 and Risks of Adverse Outcomes in COVID-19 Patients in the Primary and Secondary Care Setting
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Prezentacja Programu Powerpoint
Risk Markers for Cardiovascular Disease in Patients with Chronic Kidney Disease
Review of Atrial Fibrillation Outcome Trials of Oral Anticoagulant And
Customs Tariff - Schedule
Pharmaceutical Compositions Comprising Prasugrel And
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Customs Tariff - Schedule Xxi - 1
Australian Statistics on Medicines 2009
Treatment of Deep Vein Thrombosis and Pulmonary Embolism
Oral Anticoagulants
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
Therapeutic Class Overview Oral Anticoagulants
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
WO 2U11/132171 Al
The Role of Meta-Analysis in Pharmacovigilance: How Best to Combine Different Sources of Evidence About Harms?
(12) Patent Application Publication (10) Pub. No.: US 2009/0098207 A1 Malakhov Et Al
Pharmaceutical Appendix to the Harmonized Tariff Schedule
ICD-10-CM TABLE of DRUGS and CHEMICALS
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
ICD-10-CM Table of Drugs 2019
2018 Antithrombic Therapy for Atrial Fibrillation Chest Guideline Expert Panel Report
Supplementary Material Table S1. the 380 Compounds Used in the Training Set, the 172 Compounds Used in the Test Set, with Thei
Antithrombotic Therapy in Patients Undergoing Coronary Artery Bypass Grafting: a Systematic Review and Network Meta-Analysis
Prognostic Analysis of Different Therapeutic Regimens in Patients with Acute Cardiogenic Cerebral Embolism Lan Hu1,2, Guangxin Duan3, Yuan Xu2 and Yongjun Cao1*
(12) Patent Application Publication (10) Pub. No.: US 2013/0095095 A1 Lines (43) Pub
Resolution Ap (2000) 1
ATC Code Title
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Original Article a Comparison of Indobufen and Low-Molecular